Firefly Neuroscience, Inc. (AIFF)

Firefly Neuroscience, Inc. is a technology company that applies artificial intelligence to brain health. Its Brain Network Analytics platform, known as BNA, analyzes electroencephalogram (EEG) recordings and compares them against a large database of brain scans to produce measures of brain function that clinicians can use alongside their own assessments.

The platform has FDA clearance and is designed to help physicians evaluate and monitor patients with mental illness and neurological disorders, such as depression, dementia and attention disorders. Firefly also offers its technology and data to pharmaceutical companies to support drug development and clinical trials. The company is headquartered in Kenmore, New York, and its common stock trades on Nasdaq.